※ PTMD 2.0 database Online Browse Options

Browse result for Leukemia

※ introduction

    Leukemia (also spelled leukaemia and pronounced loo-KEE-mee-?) is a group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising, bone pain, fatigue, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy. The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, petrochemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia¡ªacute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)¡ªas well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues. Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. Five-year survival rate is 65% in the United States. In children under 15 in first-world countries, the five-year survival rate is greater than 60% or even 90%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return. In 2015, leukemia was present in 2.3 million people worldwide and caused 353,500 deaths. In 2012, it had newly developed in 352,000 people. It is the most common type of cancer in children, with three-quarters of leukemia cases in children being the acute lymphoblastic type. However, over 90% of all leukemias are diagnosed in adults, with CLL and AML being most common in adults. It occurs more commonly in the developed world.

Reference
Wiki: Leukemia



PTMD IDUniProt AccessionEntrez IDGene NameProtein NameOrganism
PTMD00452O004595296
PIK3R2
Phosphatidylinositol 3-kinase regulatory subunit beta
Homo sapiens
PTMD00870O149807514
XPO1
Exportin-1
Homo sapiens
PTMD00061O606743717
JAK2
Tyrosine-protein kinase JAK2
Homo sapiens
PTMD01052P0051925
ABL1
Tyrosine-protein kinase ABL1
Homo sapiens
PTMD00644Q025485079
PAX5
Paired box protein Pax-5
Homo sapiens
PTMD00660Q061245781
PTPN11
Tyrosine-protein phosphatase non-receptor type 11
Homo sapiens
PTMD00251Q9BYW229072
SETD2
Histone-lysine N-methyltransferase SETD2
Homo sapiens
PTMD00436Q9Y6K11788
DNMT3A
DNA -methyltransferase 3A
Homo sapiens
PTMD00113Q9Y6N76091
ROBO1
Roundabout homolog 1
Homo sapiens
PTMD00494O960287468
NSD2
Histone-lysine N-methyltransferase NSD2
Homo sapiens
PTMD00225P6843183508
H3C1
Histone H3.1
Homo sapiens
PTMD00226P094293146
HMGB1
High mobility group protein B1
Homo sapiens
PTMD00254P371737048
TGFBR2
TGF-beta receptor type-2
Homo sapiens
PTMD00198P011114893
NRAS
GTPase NRas
Homo sapiens
PTMD00498P011163845
KRAS
GTPase KRas [Cleaved into: GTPase KRas, N-terminally processed]
Homo sapiens
PTMD00219P146185315
PKM
Pyruvate kinase PKM
Homo sapiens
PTMD00896P182067414
VCL
Vinculin
Homo sapiens
PTMD00576P30307995
CDC25C
M-phase inducer phosphatase 3
Homo sapiens
PTMD00594P427023977
LIFR
Leukemia inhibitory factor receptor
Homo sapiens
PTMD00031P465271027
CDKN1B
Cyclin-dependent kinase inhibitor 1B
Homo sapiens
PTMD00224P6280512150
H4C1
Histone H4
Homo sapiens
PTMD01168Q990621441
CSF3R
Granulocyte colony-stimulating factor receptor
Homo sapiens
PTMD01307P461091399
CRKL
Crk-like protein
Homo sapiens
PTMD01394A0A7S8LV65
RUNX1/RUNX1T1
RUNX1-RUNX1T1 fusion protein
Homo sapiens
PTMD01560P2475238
ACAT1
Acetyl-CoA acetyltransferase, mitochondrial
Homo sapiens
PTMD01582P295905371
PML
Protein PML
Homo sapiens
PTMD01649P515755023
P2RX1
P2X purinoceptor 1
Homo sapiens
PTMD03586P004882162
F13A1
Coagulation factor XIII A chain
Homo sapiens
PTMD05359P499173981
LIG4
DNA ligase 4
Homo sapiens
PTMD10691Q8WZ6089857
KLHL6
Kelch-like protein 6
Homo sapiens
PTMD14365Q9ULB41007
CDH9
Cadherin-9
Homo sapiens
PTMD00636P6843331915
H3c1
Histone H3.1
Mus musculus
PTMD01053P0110339624
MYB
Transcriptional activator Myb
Gallus gallus
PTMD01096P4223020850
Stat5a
Signal transducer and activator of transcription 5A
Mus musculus
PTMD01956Q9Z1S012236
Bub1b
Mitotic checkpoint serine/threonine-protein kinase BUB1 beta
Mus musculus